FOXP3 Genetic Variation at Position -2383 C/T (rs3761549) in Patients with Breast Cancer

被引:0
|
作者
Shiri, Zahra [1 ]
Mansouri, Reza [1 ,2 ]
Haghshenas, Mohammad Reza [3 ]
Talei, Abdolrasoul [4 ,5 ]
Erfani, Nasrollah [3 ,6 ]
机构
[1] Shahid Sadoughi Univ Med Sci, Int Branch, Fac Med, Dept Immunol, Yazd, Iran
[2] Shahid Sadoughi Univ Med Sci, Hematol & Oncol Res Ctr, Yazd, Iran
[3] Shiraz Univ Med Sci, Sch Med, Shiraz Inst Canc Res, Shiraz, Iran
[4] Shiraz Univ Med Sci, Breast Dis Res Ctr, Shiraz, Iran
[5] Shiraz Univ Med Sci, Sch Med, Dept Surg, Shiraz, Iran
[6] Shiraz Univ Med Sci, Sch Med, Dept Immunol, Shiraz, Iran
关键词
Breast cancer; FOXP3; gene; Single nucleotide polymorphism; PCR-RFLP; RISK-FACTORS; T-CELLS; POLYMORPHISMS; EPIDEMIOLOGY; WOMEN; IPEX;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We investigated the possibility of an association between the C-2383T polymorphism (rs3761549) in the promoter region of the FOXP3 gene with breast cancer. Methods: The study groups consisted of 250 women diagnosed with breast cancer (case group) and 250 healthy women (control group). Polymerase chain reaction-restriction fragment length polymorphism was performed for genotyping. Results: Breast cancer cases had a C allele frequency of 455 (91%) and T allele frequency of 45 (9%). The control group had a C allele frequency of 468 (93.6%) and 32 (6.4%) for the T allele. The CC genotype was present in 206 (82.4%) patients, 43 (17.2%) patients had the CT genotype, and the TT genotype was observed in 1 (0.4%) patient. In the control group, 219 (87.6%) had the CC genotype, whereas 30 (12%) had the CT genotype, and 1 (0.4%) had the TT genotype. Statistical analysis revealed no significant differences in the distribution of alleles and genotypes between patients and controls (P>0.05). There was no significant association between genotype distribution and patients' clinicopathological factors. Conclusion: Our results do not support an association between the FOXP3 -2383 C/T polymorphism and breast cancer in a population from southern Iran.
引用
收藏
页码:299 / 304
页数:6
相关论文
共 50 条
  • [31] Homeostasis of peripheral FoxP3+ CD4+ regulatory T cells in patients with early and late stage breast cancer
    Andrew J. Rech
    Rosemarie Mick
    David E. Kaplan
    Kyong-Mi Chang
    Susan M. Domchek
    Robert H. Vonderheide
    Cancer Immunology, Immunotherapy, 2010, 59 : 599 - 607
  • [32] Homeostasis of peripheral FoxP3+ CD4+ regulatory T cells in patients with early and late stage breast cancer
    Rech, Andrew J.
    Mick, Rosemarie
    Kaplan, David E.
    Chang, Kyong-Mi
    Domchek, Susan M.
    Vonderheide, Robert H.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (04) : 599 - 607
  • [33] Migration/Differentiation-Associated LncRNA SENCR rs12420823*C/T: A Novel Gene Variant Can Predict Survival and Recurrence in Patients with Breast Cancer
    Al Ageeli, Essam
    Attallah, Samy M.
    Mohamed, Marwa Hussein
    Almars, Amany, I
    Kattan, Shahad W.
    Toraih, Eman A.
    Fawzy, Manal S.
    Darwish, Marwa K.
    GENES, 2022, 13 (11)
  • [34] Plasmacytoid dendritic cells deficient in IFNα production promote the amplification of FOXP3+ regulatory T cells and are associated with poor prognosis in breast cancer patients
    Sisirak, Vanja
    Faget, Julien
    Vey, Nelly
    Blay, Jean-Yves
    Menetrier-Caux, Christine
    Caux, Christophe
    Bendriss-Vermare, Nathalie
    ONCOIMMUNOLOGY, 2013, 2 (01):
  • [35] Vitamin D Receptor Genetic Variation and Cancer Biomarkers among Breast Cancer Patients Supplemented with Vitamin D3: A Single-Arm Non-Randomized Before and After Trial
    Kazemian, Elham
    Akbari, Mohammad Esmaeil
    Moradi, Nariman
    Gharibzadeh, Safoora
    Mondul, Alison M.
    Jamshidi-Naeini, Yasaman
    Khademolmele, Maryam
    Zarins, Katie R.
    Ghodoosi, Nasim
    Amouzegar, Atieh
    Davoodi, Sayed Hossein
    Rozek, Laura S.
    NUTRIENTS, 2019, 11 (06)
  • [36] A C->T Variation in 3′-Untranslated Region Elevates MED12 Protein Level in Breast Cancer That Relates to Better Prognosis
    Chen, Jianbin
    Wang, Tairen
    Mu, Weina
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2024, 28 (09) : 343 - 350
  • [37] The challenge of determining the impact of FUT3 tumor-associated polymorphism rs2306969 (-6951 C> T) in invasive breast cancer cells
    Jessica Catarine Frutuoso do Nascimento
    Anderson de Oliveira Vasconcelos
    Maria Aparecida Barreto Lopes Seabra
    Eduardo Isidoro Carneiro Beltrão
    Cíntia Renata Costa Rocha
    Molecular Biology Reports, 2019, 46 : 3531 - 3536
  • [38] Cytokine profile of CD4+ CD25-FoxP3+ T cells in tumor-draining lymph nodes from patients with breast cancer
    Niakan, Andisheh
    Faghih, Zahra
    Talei, Abdol-Rasoul
    Ghaderi, Abbas
    MOLECULAR IMMUNOLOGY, 2019, 116 : 90 - 97
  • [39] CYP2C8 rs11572080 and CYP3A4 rs2740574 risk genotypes in paclitaxel-treated premenopausal breast cancer patients
    Attia, Hanaa R. M.
    Kamel, Mahmoud M.
    Ayoub, Dina F.
    Abd El-Aziz, Shereen H.
    Abdel Wahed, Mai M.
    Abd El-Fattah, Safa N.
    Ablel-Monem, Mahmoud A.
    Rabah, Thanaa M.
    Helal, Amany
    Ibrahim, Mona Hamed
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [40] Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients
    Voon, Pei Jye
    Yap, Hui Ling
    Ma, Cho-Yee-Thu
    Lu, Fan
    Wong, Andrea L. A.
    Sapari, Nur Sabrina
    Soong, Richie
    Soh, Thomas I. P.
    Goh, Boon-Cher
    Lee, How-Sung
    Lee, Soo-Chin
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (06) : 1497 - 1505